Showing results (181-190 of 6,999) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Risk factors for pulmonary nodules in north China: A prospective cohort studyYu-Tong He, Ya-Chen Zhang, Gao-Feng Shi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Added prognostic value of CT characteristics and IASLC/ATS/ERS histologic subtype in surgically resected lung adenocarcinomasYoung Joo Suh, Hyun-Ju Lee, Young Tae Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Tumor spread through air spaces is a useful predictor of recurrence and prognosis in stage I lung squamous cell carcinoma, but not in stage II and IIINaoki Yanagawa, Satoshi Shiono, Makoto Endo, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)Thomas Muley, Vinzent Rolny, Ying He, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line settingMartin Reck, Marina Chiara Garassino, Martina Imbimbo, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from SwedenSalomon Tendler, Vitali Grozman, Rolf Lewensohn, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2023
Brief report on the efficacy of sotorasib in KRAS-Mutated NSCLC patients with brain metastasesAnna Baukje Lebouille-Veldman, Trent N Taros, Noah L A Nawabi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 2, 2023
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitorsSara Manglaviti, Marta Bini, Giulia Apollonio, et al.
Lung Cancer (Amsterdam, Netherlands)|August 30, 2023
A randomized double-blind trial of TQB2450 with or without anlotinib in pretreated driver-negative non-small cell lung cancerWei Zhang, Jing Wang, Qiming Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 2023
Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substagesHao Ho, Sung-Liang Yu, Hsuan-Yu Chen, et al.
Pageof 700